STOCKS TELEGRAPH

Tag: NAOV Stock

  • Surge In NanoVibronix (NAOV) Shares Sparks Market Curiosity

    Surge In NanoVibronix (NAOV) Shares Sparks Market Curiosity

    The stock market is seeing a spectacular surge in NanoVibronix, Inc. (NASDAQ: NAOV) shares, which were rising 381.88% to $14.17 as of the most recent check today. The spike seems to be driven by recent encouraging developments about NanoVibronix’s core medical product, UroShield, and its expansion of distribution in Australia, even if there was no immediate breaking news.

    Extended and Renewing Contract

    NanoVibronix announced earlier this month that it has extended and renewed its exclusive three-year distribution arrangement with Dukehill Healthcare Pty Ltd, a Queensland-based company. All Australian states are now covered by Dukehill’s distribution rights, which were formerly restricted to Queensland and New South Wales.

    This move comes after a noticeable rise in orders and questions from medical facilities, especially in Victoria and South Australia, indicating increased interest in UroShield’s potential in clinical settings.

    Increasing Trust in UroShield’s Performance

    The enlarged agreement follows an independent research that demonstrated UroShield’s efficacy in reducing catheter-associated problems and enhancing patient outcomes. The market’s favorable reaction is probably due in part to the research, which has reaffirmed NanoVibronix’s dedication to extending access to its technology.

    NAOV stressed that more patients and healthcare professionals around Australia would be able to take use of UroShield’s cutting-edge catheter care capabilities thanks to this renewed cooperation.

    Upcoming National Exposure and Clinical Engagement

    Dukehill will introduce UroShield at the 33rd National Conference on Incontinence, hosted by Continence Health Australia in Hobart in May 2025, in an effort to increase awareness and uptake even more. Clinicians from all around the nation will come together for the event, which will provide them a forum to talk about the study’s results and interact with the technology.

    The meeting is seen by NanoVibronix as a crucial chance to highlight UroShield’s therapeutic benefits and bolster its market share in Australia. NAOV seems to be well-positioned for further expansion in the healthcare technology industry due to its growing clinical relationships and growing worldwide awareness.

  • NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study

    NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study

    The share price of NanoVibronix, Inc. (NASDAQ: NAOV) increased significantly during pre-market trading, going up 79.82% to $3.92 as of the last check. The notable increase follows the publication of a successful independent study evaluating the company’s primary medical product, UroShield, by the Australian and New Zealand Continence Journal.

    An independent Validates UroShield’s Effectiveness

    The study highlights the device’s efficacy in reducing catheter-associated urinary tract infections (CAUTIs) and its potential for widespread clinical use among patients with indwelling urinary catheters (IUCs). UroShield customers showed encouraging outcomes from the independent health service research showing that Catheter blockages reduced by 70% while Catheter changes decreased by 52.3%.

    The positive impact of the device on patient care is further supported by the fact that clinicians saw less catheter-related interventions and more patient comfort. The study also discovered that UroShield decreased nursing effort and produced measurable cost savings for medical professionals.

    Better Patient Results and Cost Effectiveness

    The effectiveness of UroShield in a New Zealand District Nursing Service was described in depth in the published study, which also highlighted how it improves the quality of life for patients with IUCs. UroShield dramatically decreased catheter-associated infections and obstructions, resulting in fewer medical interventions and improved patient comfort, according to the Quality Improvement initiative.

    Furthermore, during a five-month period, the final cost analysis showed a 63.5% drop in resource consumption, mostly as a result of fewer medical interventions and emergency call-outs.

    Devices of the Future in Development

    Along with the encouraging trial findings, NanoVibronix recently reported that the design process for its next PainShield and UroShield devices was finished. In December 2024, a third-party contractor completed the creation of the prototype with an emphasis on lowering assembly costs, minimizing risk factors, and improving user ease.

    These advancements show NanoVibronix’s continuous efforts towards innovation in medical technology and supporting its prospects for further market expansion and acceptance. With these developments, NAOV is securing its position in the healthcare sector by offering innovative solutions to improve patient care and operational efficacy.

  • Upcoming Presentation: NanoVibronix Inc. (NAOV) stock Rallies After Hours

    On January 07, NanoVibronix Inc. (NAOV) announced its presentation at the upcoming H.C. Wainwright BioConnect Virtual Conference. Consequently, the stock became bullish in the after-hours on Friday.

    During the regular session, NAOV stock traded in the red with a loss of 3.88% at its close of $0.99. Following the announcement, the stock gained 6.06% to reach $1.05 in the after hours.

    The noninvasive biological response-activating devices developer, NanoVibronix Inc. was founded in 2003. Currently, its 27.95 million outstanding shares trade at a market capitalization of $27.67 million.

    H.C. Wainwright BioConnect Conference

    As per Friday’s announcement, NAOV’s Chief Executive Officer will present at the conference. Furthermore, the H.C. Wainwright BioConnect Virtual Conference will take place from January 10 to January 13, 2022.

    Mr. Murphy will provide updates on the company’s business during the presentation.

    NAOV’s VA Distribution Network Expansion

    On January 06, the company announced the expansion of its VA distribution network. Delta Medical, LLC has been added to the distribution network in order to increase the sale of NAOV’s PainShield products to Veteran’s Administration hospitals and healthcare facilities.

    Further, it is owned by Justin A. Brooks, who has vast experience in medical devices and deep-rooted relationships within the VA system.

    Previously, the company had sighed a distribution agreement with Applied Medical Solutions, LLC. Applied Medical serves as the distributor of NAOV’s PainShield products to Veteran Administration facilities throughout the U.S. Added to that, now Delta Medical will be the sub-distributor of the products for expanding its access.

    PainShieldTM

    PainShield is NOAV’s ultrasound device that delivers a localized ultrasound effect for treating pain and inducing soft tissue healing at a targeted area. Moreover, PainShield can be used in any kind of setting, be it home or work or a clinical setting. It has been shown to effectively treat chronic and acute pains without any risk of abuse as is the case with most opioid-based pain treatments.

    NAOV’s Financial Results

    On November 16, the company announced its third-quarter financial results of 2021.

    According to the results, NOAV has revenue of $499,000 in the third quarter of 2021. Comparatively, the revenue was $150,000 in Q3 of 2020. This shows a humungous increase of 233% year over year.

    In addition, the company incurred a net loss of $6.7 million in the third quarter of 2021, against $922,000 in the year-ago period. Resultantly, the net loss per basic and diluted share was $0.26 and $0.10 in the third quarter of 2021 and 2020, respectively.

  • NAOV stock has plunged in the after-hours; Find out why

    NanoVibronix Inc. (NAOV) has plunged -7.07% at $0.79 in after-market trading hours on the last check Thursday. The NAOV stock lost -10.52% to complete the last trading session at $0.85. The price range of the NAOV stock was between $0.8324 and $0.931

    How NanoVibronix differentiates its medical devices

    NanoVibronix Inc. is a medical device company that specifically focuses on the manufacturing and sale of biological response-activating device that target would recovery, pain treatment, and biofilm prevention – all done noninvasively. The NAOV stock has a research and development team in Nesher, Israel that designs medical devices using its low-intensity surface acoustic wave which is proprietary and patented. NanoVibronix sells its product directly to clients and patients along with Federaly supply agreements with the United States. Similar distributor agreements are also made with India, Israel, Europe, and other international linkages.

    The SAW technology of the company is diversified due to its low-frequency ultrasound waves for medical applications which include bacterial colonization, biofilm disruption, and pain relief.  The leading products of the company include PainShield®, UroShield®, and WoundShieldTM.

    NAOV has secured another Federal Supply Schedule deal with VA

    On 2nd March 2021, NanoVibronix Inc. (NASDAQ: NAOV) announced that it entered into another Federal Supply Schedule agreement for its UroShield urology therapy device through a service-disabled veteran organization. This supply will be ordered through the Veterans Administration (VA) to make it easier to treat veterans with UroShield.

    The NAOV stock sells its medical devices directly but it also has a supply chain agreement with governmental contracts, particularly the Federal Supply Schedule in the USA. The FSS program is managed through a contract with the General Services Administration (GSA) which provides Federal agencies a more efficient and convenient process for procuring the commercial supplies in bulk for discounts. NAOV’s PainShield – a non-opioid pain therapy was also placed on FSS by the Veterans Administration on 1st September 2019.

    The veterans use Foley catheters which have a risk of catching Catheter-Associated Urinary Tract Infection (CAUTI) which is the leading cause of secondary hospital-acquired bloodstream infection. 40 million Americans undergo Urinary Catheterization, with 0.5 million CAUTI cases and 8000 deaths related to infection, every year.

    This is the market where UroShield is really differentiated and effective because it is attached to any indwelling urinary catheter as a disposable ultrasound device which reduces biofilm and prevents CAUTI. The ultrasound low intensity waves disrupt the docking mechanism of Bacteria and prevent bacterial colonization. UroShield is also effective against preventing hospitalization – a necessary action during the COVID-19 pandemic where hospitals focus on prioritizing hospital beds for COVID patients.

    NAOV is re-adjourning its Special Meeting of Stockholders again

    On 2nd March NAOV stock announced that its Special Meeting of Stockholders scheduled for 31st march, 2021 has been adjourned and rescheduled for 14th April 2021. This was done to allow more time for stockholders to vote.

    However on 14th April, the company announced again that the Special Meeting of Stockholders has been re-adjourned. It will now reconvene on 27th April 2021, at 10 am ET and virtually take place on the link here. NAOV will continue to solicit proxies from its stockholders and encourage them to vote before April 26, 20201 11:59 pm.

  • NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises in after-hour trading. Why is it so?

    NanoVibronix Inc. (NAOV) stock rises by 7.84% in the after-hour trading session while there is no recent news available related to this gain in NAOV stock price. NanoVibronix is a medical device company specializing in the development of medical devices based on its innovative low intensity surface acoustic wave technology. This technology enables the development of low-frequency ultrasound waves for a range of medical applications, including the disruption of biofilms and bacteria invasion, as well as pain management.

    Recent Important Events

    On March 31, NAOV stock announced their Special Meeting of Stockholders, which was scheduled for March 31, 2021, that it has got postponed in order to give stockholders more time to vote. The meeting is set to take place again on April 14, 2021. NAOV would continue to receive proxies from its stockholders for the resolutions set out in the Company’s proxy statement throughout the time of postponement. Until properly repealed, proxies previously submitted in relation to the Special Meeting will be voted on at the reconvened meeting. All stockholders who have not yet voted are encouraged to do so before April 13, 2021.

    Also on March 2, 2021, NAOV revealed that through a service disabled veteran group, NAOV’s UroShield urology therapy device has been added to the Federal Supply Schedule, making it possible for Veterans being handled by the Veterans Administration to obtain and use the UroShield.

    The PainShield, NanoVibronix’s other patented product, was put on the Federal Supply Schedule on September 1, 2019, ensuring veterans’ access to non-opioid pain treatment. Veterans who have indwelling Foley catheters will now get UroShield which is a medication to prevent Catheter-Associated Urinary Tract Infections.

    Conclusion

    The postponement of Special Meeting of Stockholders could be the possible reason for this change in NAOV stock price since the meeting has yet to happen. Until the meeting takes place, we will probably witness the NAOV stock to vary quite a few time. The investors would also be looking forward to the final result of this meeting.

  • What changed for these 49 stocks in Pre Market Session

    What changed for these 49 stocks in Pre Market Session

    Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most recent rating by Citigroup, on February 18, 2020, is a Buy.
    American Airlines Group Inc. (NASDAQ: AAL) shares are trading up 4.72% at $16.85 at the time of writing. Company’s 52-week ranged between $8.25 to $30.78.
    FuelCell Energy Inc. (FCEL) is up more than 5.01% at $7.75 in pre-market hours Friday December 04, 2020. The firm recently declared the pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The stock had jumped over 1.93% to $7.38 in the last trading session.
    Before the trading started on December 04, 2020, AMC Entertainment Holdings Inc. (AMC) is up 5.51% to reach $3.83. It has been trading in a 52-week range of $1.95 to $8.78.
    Cinemark Holdings Inc. (CNK) stock soared 6.02% to $14.1 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Iterum Therapeutics plc (ITRM), a Biotechnology company, dropped about -3.8% at $0.809 in pre-market trading Friday.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 3.7% at $26.36 at the time of writing following its announcement extension of suspension of voyages. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Before the trading started on December 04, 2020, Jaguar Health Inc. (JAGX) is up 7.84% to reach $0.399. It has been trading in a 52-week range of $0.19 to $1.08.
    Transocean Ltd. (RIG), a Oil & Gas Drilling company, rose about 4.43% at $2.12 in pre-market trading Friday after declaring amendments to certain financing documents and internal reorganization transactions to resolve allegations contained in purported notices of default.
    Novan Inc. (NOVN) stock soared 19.92% to $0.67 in the pre-market trading. The most recent rating by Piper Jaffray, on January 06, 2020, is a Neutral.
    Li Auto Inc. (LI) lost over -2.48% at $31.51 in pre-market trading Friday December 04, 2020 following declaration its pricing of follow-on public offering of American depositary shares.
    Southwestern Energy Company (NYSE: SWN) shares are trading up 2.13% at $2.88 at the time of writing. Company’s 52-week ranged between $1.06 to $3.90. Analysts have a consensus price target of $2.40.
    Occidental Petroleum (OXY) is up more than 3.23% at $16.92 in pre-market hours Friday December 04, 2020. The company recently reported the release of its 2020 Climate Report, which provides a pathway detailing milestones to achieve its net-zero aspirations. The stock had jumped over 3.15% to $16.39 in the last trading session.
    Torchlight Energy Resources Inc. (TRCH) is up more than 6.9% at $0.48 in pre-market hours Friday December 04, 2020. The stock had jumped over 15.13% to $0.45 in the last trading session.
    TransGlobe Energy (TGA) grew over 2.82% at $0.659 in pre-market trading today following its agreement to merge, extend and modernize its eastern Desert concessions.
    Before the trading started on December 04, 2020, Catabasis Pharmaceuticals Inc. (CATB) is up 2.07% to reach $1.97. It has been trading in a 52-week range of $1.25 to $8.59.
    Inovio Pharmaceuticals Inc. (INO) stock moved up 8.07 percent to $13.53 in the pre-market trading after declaring the execution of an agreement with Kaneka Eurogentec S.A., for Eurogentec to manufacture INOVIO’s COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales.
    Clovis Oncology Inc. (CLVS) is down more than -4.81% at $5.15 in pre-market hours Friday December 04, 2020. The stock had jumped over 11.09% to $5.41 in the last trading session.
    Cinedigm Corp. (CIDM) gained over 71.43% at $0.96 in pre-market trading Friday December 04, 2020 after reporting that its eight additional linear streaming channels are now Available on Rad’s fast-growing global streaming platform.
    Onconova Therapeutics Inc. (ONTX) stock plunged -1.9% to $0.3143 in the pre-market trading. The most recent rating by H.C. Wainwright, on March 01, 2018, is a Buy.
    Marvell Technology Group Ltd. (MRVL) stock plunged -5.1% to $43.2 in the pre-market trading after announcing a quarterly dividend of $0.06 per share of common stock payable on January 14, 2021 to shareholders of record as of December 23, 2020. The most recent rating by Craig Hallum, on October 30, 2020, is a Buy.
    QEP Resources Inc. (QEP) stock soared 5.0% to $2.1 in the pre-market trading. The most recent rating by JP Morgan, on July 20, 2020, is a Neutral.
    Arlo Technologies Inc. (NYSE: ARLO) shares are trading up 3.09% at $7.0 at the time of writing. The company recently revealed that Matthew McRae, CEO, and Gordon Mattingly, CFO, will present at the Raymond James Virtual Technology Investors Conference on Tuesday, December 8, 2020. Company’s 52-week ranged between $1.20 to $7.75. Analysts have a consensus price target of $6.
    Before the trading started on December 04, 2020, Nxt-ID Inc. (NXTD) is down -3.91% to reach $0.41. It has been trading in a 52-week range of $0.21 to $0.89.
    Halliburton Company (HAL) gained over 3.66% at $18.68 in pre-market trading Friday December 04, 2020 following its deal with Accenture (ACN), to accelerate Halliburton’s digital supply chain transformation and support digitalization within the Company’s manufacturing function.
    United Microelectronics (UMC) stock soared 10.32% to $8.55 in the pre-market trading. The most recent rating by Credit Suisse, on October 12, 2020, is an Outperform.
    Before the trading started on December 04, 2020, Cloudera Inc. (CLDR) is up 14.85% to reach $13.3 after reporting results for its third quarter of fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $4.76 to $14.20.
    Before the trading started on December 04, 2020, Isoray Inc. (ISR) is down -4.92% to reach $0.47. It has been trading in a 52-week range of $0.35 to $1.06.
    iBio Inc. (AMEX: IBIO) shares are trading down -0.66% at $1.51 at the time of writing. The firm recently reported an agreement with Belgium-based ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. Company’s 52-week ranged between $0.14 to $7.45. Analysts have a consensus price target of $2.55.
    Centennial Resource Development Inc. (CDEV) stock soared 3.13% to $1.32 in the pre-market trading. The most recent rating by MKM Partners, on November 30, 2020, is a Neutral.
    BioCryst Pharmaceuticals Inc. (BCRX) is up more than 24.44% at $6.39 in pre-market hours Friday December 04, 2020 following the FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to prevent attacks in Hereditary Angioedema patients. The stock had jumped over 1.88% to $5.14 in the last trading session.
    Borr Drilling Limited (BORR) is up more than 6.86% at $0.854 in pre-market hours Friday December 04, 2020. The stock had dropped over -1.78% to $0.80 in the last trading session.
    Before the trading started on December 04, 2020, Blink Charging Co. (BLNK) is up 4.14% to reach $23.64 after declaring an agreement with JSC Management Group, a large Burger King franchisee, to deploy numerous EV charging stations at key Burger King locations across the Northeast. It has been trading in a 52-week range of $1.25 to $34.67.
    Banco Santander S.A. (SAN) grew over 3.74% at $3.33 in pre-market trading today.
    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 2.98% at $8.3 at the time of writing. Company’s 52-week ranged between $2.17 to $17.45.
    InVivo Therapeutics Holdings Corp. (NVIV) lost over -4.67% at $0.6101 in pre-market trading Friday December 04, 2020.
    Aehr Test Systems (AEHR), a Semiconductor Equipment & Materials company, dropped about -8.74% at $1.88 in pre-market trading Friday after receiving $4.3 million order for initial FOX-XP™ test cell for production test of mobile sensor devices.
    ICICI Bank Limited (IBN) grew over 4.48% at $13.75 in pre-market trading today.
    NanoVibronix Inc. (NAOV) stock moved down -7.96 percent to $1.04 in the pre-market trading following the announcement of $6.0 million private placement.
    DocuSign Inc. (DOCU), a Software – Application company, rose about 4.43% at $241.25 in pre-market trading Friday.
    Dada Nexus Limited (DADA) is up more than 4.4% at $47.2 in pre-market hours Friday December 04, 2020 after reporting that Dada Now has partnered with dozens of cake chain brands across China, doubling the number of cooperating stores year-over-year as of November 2020. The stock had dropped over -15.65% to $45.21 in the last trading session.
    Salarius Pharmaceuticals Inc. (SLRX) stock moved up 1.85 percent to $1.1 in the pre-market trading.
    Auris Medical Holding Ltd. (NASDAQ: EARS) shares are trading down -3.23% at $3.3 at the time of writing after it pricing $8,000,000 common shares offering priced at-the-market. Company’s 52-week ranged between $0.65 to $6.60. Analysts have a consensus price target of $2.50.
    Acasti Pharma Inc. (ACST) lost over -2.94% at $0.33 in pre-market trading Friday December 04, 2020.
    Micro Focus International plc (MFGP) is up more than 6.3% at $6.07 in pre-market hours Friday December 04, 2020. The firm recently declared the findings of its ‘Endless Modernization’ research with Standish Group. The stock had jumped over 14.66% to $5.71 in the last trading session.
    BP p.l.c. (BP), a Oil & Gas Integrated company, rose about 4.54% at $22.33 in pre-market trading Friday.
    Tantech Holdings Ltd (NASDAQ: TANH) shares are trading up 4.27% at $1.71 at the time of writing after announcing the launch by its subsidiary, Shangchi Automobile Co., Ltd. (“Shangchi Automobile”), of its newest highly innovative driverless and autonomous street sweeper. Company’s 52-week ranged between $0.81 to $3.65.
    Trine Acquisition Corp. (TRNE) gained over 7.05% at $15.49 in pre-market trading Friday December 04, 2020.
    Enlivex Therapeutics Ltd. (ENLV) grew over 5.26% at $12.0 in pre-market trading today after reporting positive interim results of an investigator-initiated Phase II clinical trial evaluating AllocetraTM in severe and critical COVID-19 patients.

  • 41 Stocks Making Sharp Moves in Pre Market Session

    41 Stocks Making Sharp Moves in Pre Market Session

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading down -4.55% at $1.05 at the time of writing after announcing $6.0 million private placement. Company’s 52-week ranged between $0.54 to $3.50.
    Merrimack Pharmaceuticals Inc. (MACK) stock plunged -6.93% to $6.04 in the pre-market trading. The most recent rating by JP Morgan, on October 07, 2016, is a Neutral.
    Curis Inc. (CRIS) is down more than -5.85% at $1.77 in pre-market hours Thursday December 03, 2020 after declaring that it will host Virtual Event to discuss CA-4948 clinical data. The stock had jumped over 22.88% to $1.88 in the last trading session.
    Before the trading started on December 03, 2020, Obalon Therapeutics Inc. (OBLN) is down -8.62% to reach $1.06. It has been trading in a 52-week range of $0.62 to $2.14.
    Artelo Biosciences Inc. (ARTL) grew over 7.53% at $0.7065 in pre-market trading today following announcement its appointment of drug discovery and development veteran Gregory R. Reyes, M.D., Ph.D. to the Company’s Board of Directors.
    Acorda Therapeutics Inc. (ACOR), a Biotechnology company, dropped about -3.54% at $0.79 in pre-market trading Thursday.
    Ampio Pharmaceuticals Inc. (AMPE) is up more than 6.8% at $1.1 in pre-market hours Thursday December 03, 2020 after declaring its phase I study for Inhaled Ampion advances to completing enrollment of COVID-19 patients with respiratory distress. The stock had jumped over 12.65% to $1.03 in the last trading session.
    Nxt-ID Inc. (NASDAQ: NXTD) shares are trading down -6.11% at $0.446 at the time of writing. Company’s 52-week ranged between $0.21 to $0.89.
    OrganiGram Holdings Inc. (OGI) stock moved down -2.86 percent to $1.36 in the pre-market trading. The company recently released fourth quarter 2020 results.
    InVivo Therapeutics Holdings Corp. (NVIV) gained over 14.27% at $0.7999 in pre-market trading Thursday December 03, 2020.
    HEXO Corp. (HEXO) lost over -5.98% at $1.1 in pre-market trading Thursday December 03, 2020 as the firm recently revealed that it has repositioned the UP Cannabis brand with a differentiator of 20% THC or higher in all dried flower products, every time.
    Before the trading started on December 03, 2020, Aurora Cannabis Inc. (ACB) is down -2.92% to reach $10.63. It has been trading in a 52-week range of $3.71 to $32.88.
    Before the trading started on December 03, 2020, Golar LNG Limited (GLNG) is down -6.67% to reach $8.75 after declaring that it intends to offer, issue and sell to the public 11,000,000 common shares, par value $1.00 per share, through an underwritten public offering. It has been trading in a 52-week range of $4.54 to $15.24.
    Aeterna Zentaris Inc. (AEZS) stock soared 3.1% to $0.455 in the pre-market trading. The most recent rating by Maxim Group, on July 19, 2017, is a Buy.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares are trading up 9.23% at $4.26 at the time of writing after reporting that it has screened the first patients in a global trial of its oral insulin capsule ORMD-0801 for the treatment of Nonalcoholic steatohepatitis (NASH). Company’s 52-week ranged between $2.40 to $6.05. Analysts have a consensus price target of $5.50.
    Ashford Hospitality Trust Inc. (AHT), a REIT – Hotel & Motel company, rose about 7.36% at $2.48 in pre-market trading Thursday.
    Ideanomics Inc. (IDEX) grew over 0.86% at $2.35 in pre-market trading today. The technology firm lately declared that its subsidiary, Tree Technologies Sd. Bhd., which owns the Treeletrik brand, has hired Richard Teoh as its Chief Financial Officer.
    AIkido Pharma Inc. (AIKI) is down more than -2.2% at $0.59 in pre-market hours Thursday December 03, 2020. The stock had jumped over 8.94% to $0.60 in the last trading session.
    NIO Limited (NIO), a Auto Manufacturers company, dropped about -2.21% at $46.92 in pre-market trading Thursday after providing its November 2020 delivery results.
    Genius Brands International Inc. (GNUS) is up more than 2.14% at $1.43 in pre-market hours Thursday December 03, 2020. The stock had jumped over 5.26% to $1.40 in the last trading session.
    Micro Focus International plc (MFGP) gained over 2.81% at $5.12 in pre-market trading Thursday December 03, 2020 following the publication its findings of ‘Endless Modernization’ research with Standish Group.
    Trine Acquisition Corp. (NYSE: TRNE) shares are trading up 6.44% at $14.22 at the time of writing. Company’s 52-week ranged between $9.40 to $13.94.
    Before the trading started on December 03, 2020, Borr Drilling Limited (BORR) is down -6.29% to reach $0.7625. The firm recently declared unaudited results for the three and nine months ended September 30, 2020. It has been trading in a 52-week range of $0.24 to $9.12.
    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -2.83% at $22.35 in pre-market trading Thursday.
    Boxlight Corporation (BOXL) lost over -2.53% at $1.54 in pre-market trading Thursday December 03, 2020. An education technology firm recently reported that Shaun Marklew has been appointed as Chief Technology Officer and Patrick Foley will be appointed as Chief Financial Officer on January 16, 2021.
    Before the trading started on December 03, 2020, Pyxis Tankers Inc. (PXS) is up 10.87% to reach $1.02. It has been trading in a 52-week range of $0.62 to $1.37.
    Orbital Energy Group Inc. (OEG) is down more than -3.1% at $1.25 in pre-market hours Thursday December 03, 2020 following announcement its wholly-owned transmission & distribution division, Orbital Power Services signed a Master Services Agreement with a midwestern investor-owned utility.
    Telefonica S.A. (TEF) is down more than -2.64% at $4.43 in pre-market hours Thursday December 03, 2020. The stock had jumped over 1.56% to $4.55 in the last trading session.
    Longview Acquisition Corp. (NYSE: LGVW) shares are trading up 7.86% at $15.79 at the time of writing. Company’s 52-week ranged between $9.34 to $17.99.
    UP Fintech Holding Limited (NASDAQ: TIGR) shares are trading up 3.51% at $5.61 at the time of writing. Company’s 52-week ranged between $2.03 to $7.60.
    Veru Inc. (VERU) gained over 10.39% at $3.4 in pre-market trading Thursday December 03, 2020.
    Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 2.46% at $0.6414 in pre-market trading today.
    Before the trading started on December 03, 2020, Orange S.A. (ORAN) is down -5.39% to reach $12.28 after reporting that it plans to launch a conditional voluntary public takeover bid on all the shares of Orange Belgium that it does not yet own. It has been trading in a 52-week range of $9.93 to $16.08.
    Switchback Energy Acquisition Corporation (SBE) gained over 2.27% at $30.17 in pre-market trading Thursday December 03, 2020.
    Nano Dimension Ltd. (NNDM), a Computer Hardware company, rose about 4.69% at $6.7 in pre-market trading Thursday after closing the previously reported registered direct offering of 11,960,160 of the Company’s American Depositary Shares at a price of $5.00 per ADS.
    Harmony Gold Mining Company Limited (HMY) is down more than -2.42% at $4.44 in pre-market hours Thursday December 03, 2020. The stock had dropped over 0.00% to $4.55 in the last trading session.
    Waddell & Reed Financial Inc. (WDR) stock moved up 46.33 percent to $24.89 in the pre-market trading after declaring a merger agreement with Macquarie Asset Management, under which Macquarie would acquire Waddell & Reed Financial, Inc. for $1.7 Billion.
    Limelight Networks Inc. (LLNW) stock plunged -2.78% to $4.2 in the pre-market trading. The most recent rating by Goldman, on November 30, 2020, is a Neutral.
    Before the trading started on December 03, 2020, XP Inc. (XP) is down -1.88% to reach $39.65 after announcing pricing of public follow-on offering. It has been trading in a 52-week range of $15.50 to $52.94.
    CBAK Energy Technology Inc. (NASDAQ: CBAT) shares are trading up 2.75% at $7.1 at the time of writing. Company’s 52-week ranged between $0.36 to $11.40.
    Splunk Inc. (SPLK) tumbled over -20.5% at $163.69 in pre-market trading today as the firm released fiscal third quarter 2021 financial results.

  • 35 stocks making the biggest moves premarket today

    35 stocks making the biggest moves premarket today

    FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.

    SCWorx Corp. (NASDAQ: WORX) shares are trading down -6.76% at $2.07 at the time of writing. Company’s 52-week ranged between $1.00 to $14.88.

    Nano Dimension Ltd. (NNDM) lost over -12.1% at $5.74 in pre-market trading Monday, November 30, 2020, after announcing that it has entered into definitive agreements with investors for the sale of 11,960,160 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.00 per ADS pursuant to a registered direct offering.

    Moderna Inc. (MRNA) is up more than 9.38% at $138.95 in pre-market hours on Monday, November 30, 2020 after the firm today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. The stock had jumped over 16.35% to $127.03 in the last trading session.

    FreightCar America Inc. (NASDAQ: RAIL) shares are trading down -3.99% at $2.65 at the time of writing. Company’s 52-week ranged between $0.73 to $2.87. Analysts have a consensus price target of $4.50.

    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -3.25% at $27.09 in pre-market trading Monday. The firm recently declared that it has acquired the EV charging operator U-Go Stations, Inc. and its portfolio of 44 DCFC charging locations.

    Zomedica Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, dropped about -1.12% at $0.1324 in pre-market trading Monday.

    GameStop Corp. (GME) is up more than 4.1% at $16.74 in pre-market hours Monday November 30, 2020 after declaring 2020 cyber week deals. The stock had jumped over 9.02% to $16.08 in the last trading session. GameStop Announces 2020 Cyber Week Deals.

    Riot Blockchain Inc. (RIOT) grew over 8.64% at $6.79 in pre-market trading today.

    Verastem Inc. (VSTM) stock moved up 5.03 percent to $2.09 in the pre-market trading after reporting the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, and defactinib, its FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC).

    Tuniu Corporation (TOUR) gained over 6.58% at $3.4 in pre-market trading on Monday, November 30, 2020. Before the trading started on November 30, 2020.

    Novavax Inc. (NVAX) is down -8.31% to reach $115.25 after providing an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix‑M™. It has been trading in a 52-week range of $3.65 to $189.40.

    Occidental Petroleum Corporation (NYSE: OXY) shares are trading down -2.36% at $16.17 at the time of writing. Company’s 52-week ranged between $8.52 to $47.58. Analysts have a consensus price target of $18.

    RMG Acquisition Corp. (RMG) stock soared 6.6% to $18.1 in the pre-market trading. The firm recently revealed that the close of business on Tuesday, December 1, 2020, has been set as the record date for the determination of stockholders eligible to receive the proxy and vote at the special meeting to be held to consider and approve the previously announced merger with Romeo Systems, Inc., a Delaware corporation.

    Uxin Limited (UXIN) stock soared 2.53% to $1.62 in the pre-market trading. The most recent rating by JP Morgan, on October 23, 2019, is a Neutral.

    ReneSola Ltd (NYSE: SOL) shares are trading up 8.02% at $8.08 at the time of writing. The technology company recently announced the closing of the sale of a portfolio of operating projects located in the United Kingdom to Atmosclear Investments Ltd, an European renewable energy and cleantech private equity group. Company’s 52-week ranged between $0.85 to $5.67. Analysts have a consensus price target of $22.

    Kandi Technologies Group Inc. (KNDI) tumbled over -2.28% at $13.31 in pre-market trading today after CBAK Energy and Kandi Group signed a supply framework agreement.

    Vaxart Inc. (VXRT) is up more than 4.84% at $7.37 in pre-market hours on Monday, November 30, 2020. The stock had jumped over 9.84% to $7.03 in the last trading session. Before the trading started on November 30, 2020.

    Alibaba Group Holding Limited (BABA) is down -2.3% to reach $270.13. The internet retail company has been named a leader in Gartner’s 2020 Magic Quadrant for Cloud Database Management Systems. It has been trading in a 52-week range of $169.95 to $319.32.

    EyePoint Pharmaceuticals Inc. (EYPT) stock soared 1.97% to $0.55 in the pre-market trading. The most recent rating by B. Riley FBR, on April 06, 2020, is a Neutral.

    Canaan Inc. (NASDAQ: CAN) shares are trading down -7.83% at $5.3 at the time of writing after releasing its unaudited financial results for the three months ended September 30, 2020. Company’s 52-week ranged between $1.76 to $8.69.

    Heat Biologics Inc. (NASDAQ: HTBX) shares are trading down -0.88% at $1.13 at the time of writing. Company’s 52-week ranged between $0.19 to $4.30. Analysts have a consensus price target of $4.

    Yunji Inc. (YJ), an Internet Retail company, dropped about -7.35% at $3.53 in pre-market trading Monday. The firm recently declared its unaudited financial results for the third quarter ended September 30, 2020.

    India Globalization Capital Inc. (IGC) gained over 22.63% at $2.33 in pre-market trading Monday November 30, 2020.

    Oramed Pharmaceuticals Inc. (ORMP) stock moved up 38.65 percent to $6.17 in the pre-market trading. The healthcare firm recently reported that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D). Before the trading started on November 30, 2020.

    Schlumberger Limited (SLB) is down -2.06% to reach $21.43. It has been trading in a 52-week range of $11.87 to $41.14.

    Ocugen Inc. (OCGN) stock plunged -1.71% to $0.294 in the pre-market trading. The firm recently revealed that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen, will speak on “The Promise of Cell & Gene Therapies: Regulatory and Reimbursement Roadblocks” at Xconomy’s Xcelerating Life Sciences New York & Philadelphia Virtual Event on December 3 at 10:30 a.m. Before the trading started on November 30, 2020.

    Gold Fields Limited (GFI) is down -2.52% to reach $8.5. It has been trading in a 52-week range of $3.79 to $14.90. Before the trading started on November 30, 2020.

    Marathon Patent Group Inc. (MARA) is up 15.65% to reach $4.95. It has been trading in a 52-week range of $0.35 to $6.05.

    Kingsoft Cloud Holdings Limited (KC) stock soared 5.13% to $43.69 in the pre-market trading after reporting that it will be included in the MSCI China Index, effective after the U.S. market close on November 30, 2020. The most recent rating by Goldman, on June 29, 2020, is a Buy.

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading up 5.26% at $0.8 at the time of writing. Company’s 52-week ranged between $0.54 to $3.50.

    Waitr Holdings Inc. (WTRH) stock moved down -1.46 percent to $3.38 in the pre-market trading.

    Hennessy Capital Acquisition Corp. IV (HCAC) gained over 9.0% at $13.69 in pre-market trading on Monday, November 30, 2020.

    Trevena Inc. (TRVN) stock plunged -4.67% to $2.45 in the pre-market trading. The most recent rating by Guggenheim, on September 14, 2020, is a Buy.

    Suncor Energy Inc. (NYSE: SU) shares are trading down -0.58% at $17.15 at the time of writing. The firm lately publicized that it, together with the other Syncrude joint venture owners – Imperial Oil Resources Limited, CNOOC Oil Sands Canada, and Sinopec Oil Sands Partnership – have agreed in principle for Suncor to become the operator of the Syncrude project by the end of 2021. Company’s 52-week ranged between $9.60 to $34.56.

  • Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    Why NanoVibronix Inc [NAOV] Is the Stock to Watch after UroShield® Approval

    NanoVibronix Inc [NASDAQ: NAOV] is on a roll this morning. The stock started gaining upside momentum pre-market when it gained by over 80%, and it’s not easing up. The stock’s upside momentum started after the company announced that the U.S FDA had given it the authorization to sell UroShield® in the U.S market. The FDA stated that UroShield® can apply the Intended Use Code 081.006: Enforcement Discretion Per Final Guidance. It can also use the FDA Product code QMK.

    The FDA authorization has opened the way for the company to start shipping UroShield® to the U.S during the COVID-19 pandemic. This effectively opens up the company’s market at a time when a product like UroShield® is needed in the market.  That’s because, by design, it helps prevent incidents of CAUTI in people suffering from ailments that need the long-term use of indwelling catheters.

    UroShield® achieves this because it is ultrasound-based, which means it is uniquely positioned to stop the buildup of bacteria on urinary catheters that are put inside. By its design, it helps cut on the possibility of catheter-related urinary tract infections, while also cutting on the possibility of CAUTI incidence in people that need long-term catheterization.

    Commenting on the breakthrough, CEO Brian Murphy stated that the FDA continued to carry out its mandate of protecting the public through various means that include shortening the time needed to review new medical devices that are beneficial to the public during the COVID-19 period.   He added that it is on this basis that the FDA approved UroShield® for its ability to lower urinary tract infections. The CEO also touched on the uniqueness of the product stating that at the moment, the company was not aware of any other devices that have the ability to avoid catheter-linked urinary tract infections with the same level of efficiency as UroShield®.

    From an investor perspective, the approval of UroShield® is a big deal for this stock’s value. That’s because it offers the company a foothold in one of the largest markets in the world.  Demand in the U.S is likely to be driven up by COVID-19 has led to an increase in people that need catheterization and the fact that UroShield® has no close competitors in the U.S. This points to higher revenues in the short-term, and a significant increase in the company’s intrinsic value.

    About NanoVibronix Inc

    NanoVibronix Inc makes and sells non-invasive devices that help prevent biofilm, and in pain therapy. It is headquartered in Elmsford, New York.